[甲型血友病患者中的VIII因子弱抑制剂] - Suppr

Suppr

超能文献

[The weak inhibitors of factor VIII in patients with hemophilia A].

作者信息

Mayer G, Noel G, Kalogjera V, Waitz R

出版信息

Blut. 1969;19(9):517-28. doi: 10.1007/BF01633604.

DOI:10.1007/BF01633604

PMID:5369477

Abstract

摘要

相似文献

[The weak inhibitors of factor VIII in patients with hemophilia A].[甲型血友病患者中的VIII因子弱抑制剂]

Blut. 1969;19(9):517-28. doi: 10.1007/BF01633604.

[Determination of factor VIII inhibitor in hemophiliacs].

Minerva Pediatr. 1976 Nov 17;28(36):2181-5.

[Relationships of factor VIII (antihemophilic globulin) and its weak inhibitors with the spleen. Effect of adrenaline on splenectomized subjects, on splenomegaly and on patients presenting a weak factor VIII inhibitor].[因子VIII（抗血友病球蛋白）及其弱抑制剂与脾脏的关系。肾上腺素对脾切除患者、脾肿大患者及出现弱因子VIII抑制剂患者的影响]

Haematol Lat. 1971 Jul-Sep;13(3):185-206.

Acquired circulating anticoagulants in hemophilia A.

N Engl J Med. 1969 Oct 16;281(16):866-73. doi: 10.1056/NEJM196910162811603.

Factor VIII inhibitor by-passing activity (FEIBA) in the management of patients with factor VIII inhibitors.凝血因子VIII抑制剂旁路活性制剂（FEIBA）在治疗凝血因子VIII抑制剂患者中的应用

Thromb Res. 1977 Nov;11(5):643-51. doi: 10.1016/0049-3848(77)90022-6.

[Treatment of hemophilia with immunologic inhibitor of factor VIII by using "activated" coagulant fractions].

Nouv Presse Med. 1975 Oct 25;4(36):2571-4.

[Factor VIII inhibitors].[凝血因子VIII抑制剂]

Rev Clin Esp. 1968 Apr 30;109(2):129-36.

Letter: Treatment of inhibitors to factor VIII with activated prothrombin concentrate.

N Engl J Med. 1974 Nov 14;291(20):1087.

Hereditary hemorrhagic telangiectasia and factor VIII inhibitor.遗传性出血性毛细血管扩张症与凝血因子VIII抑制剂

South Med J. 1985 May;78(5):623-4. doi: 10.1097/00007611-198505000-00030.

The physiologic basis for therapy of classic hemophilia (factor 8 deficiency) and related disorders. Combined clinical staff conference at the National Institutes of Health.

Ann Intern Med. 1967 Oct;67(4):856-82.

引用本文的文献

Serum immunoglobulins in patients with congenital coagulation defects and their relatives.

Z Kinderheilkd. 1971;109(3):199-210. doi: 10.1007/BF00442269.

本文引用的文献

Hemophilia; a report of the mechanism of the development and action of an anticoagulant in two cases.血友病；两例抗凝剂作用机制及发展过程的报告

Blood. 1947 Nov;2(6):505-18.

Circulating anticoagulant as a cause of hemorrhagic diathesis in man.循环抗凝物质作为人类出血素质的一个原因。

Bull Johns Hopkins Hosp. 1948 Oct;83(4):288-96.

ELECTROPHORETIC ISOLATION OF A CIRCULATING ANTICOAGULANT.循环抗凝剂的电泳分离

J Clin Invest. 1946 Nov;25(6):814-5. doi: 10.1172/JCI101768.

Refractoriness in hemophilia to coagulation-promoting agents: whole blood and plasma derivatives.

Blood. 1950 May;5(5):401-20.

[Mediterranean blood disorder and congenital malformations in the family of a hemophiliac].[一名血友病患者家族中的地中海血液疾病与先天性畸形]

Prog Med (Napoli). 1951 May 31;7(10):294-6.

Researches on a circulating anticoagulant in a hemophiliac.对一名血友病患者体内循环抗凝物质的研究。

Blood. 1951 Mar;6(3):233-41.

Resistance to transfusion in hemophilia and deuterohemophilia.血友病和次血友病中的输血抵抗

Stanford Med Bull. 1955 May;13(2):188-93.

Acquired circulating anticoagulant in classical hemophilia.经典型血友病中的获得性循环抗凝物质。

Scand J Clin Lab Invest. 1961;13:535-44. doi: 10.3109/00365516109137322.

Formation of an inhibitor against factor VII as a postoperative complication in a severe case of hemophilia A.在一例重度甲型血友病患者中，术后出现针对凝血因子VII的抑制剂，作为一种术后并发症。

Thromb Diath Haemorrh. 1962 Mar 15;7:27-34.

A method for the study of antihaemophilic globulin inhibitors with reference to six cases.

Br J Haematol. 1959 Oct;5:379-95. doi: 10.1111/j.1365-2141.1959.tb04049.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验